These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 17896996)

  • 1. Juvenile neuronal ceroid-lipofuscinosis (Batten disease): a brief review and update.
    Rakheja D; Narayan SB; Bennett MJ
    Curr Mol Med; 2007 Sep; 7(6):603-8. PubMed ID: 17896996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CLN3p impacts galactosylceramide transport, raft morphology, and lipid content.
    Rusyn E; Mousallem T; Persaud-Sawin DA; Miller S; Boustany RM
    Pediatr Res; 2008 Jun; 63(6):625-31. PubMed ID: 18317235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Over-expression of CLN3P, the Batten disease protein, inhibits PANDER-induced apoptosis in neuroblastoma cells: further evidence that CLN3P has anti-apoptotic properties.
    Narayan SB; Rakheja D; Pastor JV; Rosenblatt K; Greene SR; Yang J; Wolf BA; Bennett MJ
    Mol Genet Metab; 2006 Jun; 88(2):178-83. PubMed ID: 16515873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osmoregulation of ceroid neuronal lipofuscinosis type 3 in the renal medulla.
    Stein CS; Yancey PH; Martins I; Sigmund RD; Stokes JB; Davidson BL
    Am J Physiol Cell Physiol; 2010 Jun; 298(6):C1388-400. PubMed ID: 20219947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Insights in Elucidation of Possible Molecular Mechanisms of the Juvenile Form of Batten Disease.
    Shematorova EK; Shpakovski GV
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33137890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of CLN3, the gene mutated in juvenile neuronal ceroid lipofuscinosis, leads to metabolic impairment and autophagy induction in retinal pigment epithelium.
    Zhong Y; Mohan K; Liu J; Al-Attar A; Lin P; Flight RM; Sun Q; Warmoes MO; Deshpande RR; Liu H; Jung KS; Mitov MI; Lin N; Butterfield DA; Lu S; Liu J; Moseley HNB; Fan TWM; Kleinman ME; Wang QJ
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165883. PubMed ID: 32592935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcript and in silico analysis of CLN3 in juvenile neuronal ceroid lipofuscinosis and associated mouse models.
    Chan CH; Mitchison HM; Pearce DA
    Hum Mol Genet; 2008 Nov; 17(21):3332-9. PubMed ID: 18678598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of the Caenorhabditis elegans homologues of the CLN3 gene, involved in human juvenile neuronal ceroid lipofuscinosis, causes a mild progeric phenotype.
    de Voer G; van der Bent P; Rodrigues AJ; van Ommen GJ; Peters DJ; Taschner PE
    J Inherit Metab Dis; 2005; 28(6):1065-80. PubMed ID: 16435200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CLN3P, the Batten disease protein, localizes to membrane lipid rafts (detergent-resistant membranes).
    Rakheja D; Narayan SB; Pastor JV; Bennett MJ
    Biochem Biophys Res Commun; 2004 May; 317(4):988-91. PubMed ID: 15094366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-Complementary AAV9 Gene Delivery Partially Corrects Pathology Associated with Juvenile Neuronal Ceroid Lipofuscinosis (CLN3).
    Bosch ME; Aldrich A; Fallet R; Odvody J; Burkovetskaya M; Schuberth K; Fitzgerald JA; Foust KD; Kielian T
    J Neurosci; 2016 Sep; 36(37):9669-82. PubMed ID: 27629717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profound infantile neuroretinal dysfunction in a heterozygote for the CLN3 genetic defect.
    de los Reyes E; Dyken PR; Phillips P; Brodsky M; Bates S; Glasier C; Mrak RE
    J Child Neurol; 2004 Jan; 19(1):42-6. PubMed ID: 15032383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel role of the Batten disease gene CLN3: association with BMP synthesis.
    Hobert JA; Dawson G
    Biochem Biophys Res Commun; 2007 Jun; 358(1):111-6. PubMed ID: 17482562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel in-frame mutation in
    Sher M; Farooq M; Abdullah U; Ali Z; Faryal S; Zakaria M; Ullah F; Bukhari H; Møller RS; Tommerup N; Baig SM
    Int J Neurosci; 2019 Sep; 129(9):890-895. PubMed ID: 30892110
    [No Abstract]   [Full Text] [Related]  

  • 14. A novel c.1135_1138delCTGT mutation in CLN3 leads to juvenile neuronal ceroid lipofuscinosis.
    Drack AV; Miller JN; Pearce DA
    J Child Neurol; 2013 Sep; 28(9):1112-6. PubMed ID: 23877479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippocampal volumes in juvenile neuronal ceroid lipofuscinosis: a longitudinal magnetic resonance imaging study.
    Tokola AM; Salli EK; Åberg LE; Autti TH
    Pediatr Neurol; 2014 Feb; 50(2):158-63. PubMed ID: 24411222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of Kv4.2/KChIP3 interaction by the ceroid lipofuscinosis neuronal 3 protein CLN3.
    Seifert C; Storch S; Bähring R
    J Biol Chem; 2020 Aug; 295(34):12099-12110. PubMed ID: 32641494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CLN3 regulates endosomal function by modulating Rab7A-effector interactions.
    Yasa S; Modica G; Sauvageau E; Kaleem A; Hermey G; Lefrancois S
    J Cell Sci; 2020 Mar; 133(6):. PubMed ID: 32034082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vision loss in juvenile neuronal ceroid lipofuscinosis (CLN3 disease).
    Ouseph MM; Kleinman ME; Wang QJ
    Ann N Y Acad Sci; 2016 May; 1371(1):55-67. PubMed ID: 26748992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synapse alterations precede neuronal damage and storage pathology in a human cerebral organoid model of CLN3-juvenile neuronal ceroid lipofuscinosis.
    Gomez-Giro G; Arias-Fuenzalida J; Jarazo J; Zeuschner D; Ali M; Possemis N; Bolognin S; Halder R; Jäger C; Kuper WFE; van Hasselt PM; Zaehres H; Del Sol A; van der Putten H; Schöler HR; Schwamborn JC
    Acta Neuropathol Commun; 2019 Dec; 7(1):222. PubMed ID: 31888773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A galactosylceramide binding domain is involved in trafficking of CLN3 from Golgi to rafts via recycling endosomes.
    Persaud-Sawin DA; McNamara JO; Rylova S; Vandongen A; Boustany RM
    Pediatr Res; 2004 Sep; 56(3):449-63. PubMed ID: 15240864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.